Ellen Matloff, a certified genetic counselor and president and CEO of My Gene Counsel, explains that, “Some patients who had 23andMe testing believed that they had been screened for all mutations in BRCA1 and BRCA2. In reality, they had only been screened for the three common Jewish BRCA mutations – a result which is almost meaningless in anyone not of Jewish ancestry.”
Recent Posts
- Looking Back on the 10-year Anniversary of the SCOTUS Decision
- Genetic Testing Challenges in Oncology: Karyotype, Germline Clues in Somatic Diagnosis Lost in Translation
- Genetic Testing Challenges in Oncology: Patient with Pending Bill has BRCA1 Result Withheld
- Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers
- NSGC 2022 Poster Presentation